Atea Pharmaceuticals, Inc. [●] Shares of Common Stock Underwriting AgreementUnderwriting Agreement • October 26th, 2020 • Atea Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Atea Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] shares of Common Stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [●] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
ATEA PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • October 26th, 2020 • Atea Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of ______________, 20[20] between Atea Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and [Name] (“Indemnitee”).
Employment AgreementEmployment Agreement • October 26th, 2020 • Atea Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (this “Agreement”), dated as of October 25, 2020, is made by and between Atea Pharmaceuticals, Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Andrea Corcoran (“Executive”) (collectively referred to herein as the “Parties” or individually referred to as a “Party”), and will become effective, if at all, upon the date of the Company’s initial public offering of stock (“IPO”) pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “Effective Date”).
